Article references (18 references )

  1. WHO. Global tuberculosis report 2017. Accessed November 20 2018.

  2. WHO. Treatment of tuberculosis: guidelines. 4th ed, Genève. 2010. Google Scholar

  3. Chaabane NB, Mansour WB, Hellara O, Melki W, Loghmeri H, Bdioui F et al. La tuberculose gastro-intestinale. Hépato Gastro. 2012; 19(1): 28-35. Google Scholar

  4. Bell LCK, Breen R, Miller F, Noursadeghi M, Lipman N. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. International Journal of Infectious Diseases. 2015; 32: 39-45. PubMed | Google Scholar

  5. Mjid M, Cherif J, Salah NB, Toujani S, Ouahchi H, Zakhama B et al. Epidemiology of tuberculosis. Rev Pneumol Clin. 2014; 71(2-3): 67-72. PubMed | Google Scholar

  6. Diallo AB, Kollo AI, Camara M, Lo S, Ossoga GW, Mbow M et al. Performance du GeneXpert MTB/RIF® dans le diagnostic de la tuberculose extra-pulmonaire à Dakar: 2010-2015. Pan African Medical Journal. 2016; 25: 129. PubMed | Google Scholar

  7. Sharif A, Akhtar T, Zia N. Intestinal Obstruction-Etiological and Treatment Outcome. Journal of Rawalpindi Medical College. 2015; 19(3): 215-219. Google Scholar

  8. Chong VH, Lim KS. Gastrointestinal tuberculosis. Singapore Med J. 2009; 50(6): 638. PubMed | Google Scholar

  9. Brown CS, Smith CJ, Breen RA, Ormerod LP, Mittal R, Fisk M et al. Determinant of treatment-related paradoxical reactions during anti-tuberculous therapy: a case control study. BMC Infectious Diseases. 2016; 16: 479. Google Scholar

  10. Chambers ST, Hendrickse WA, Record C, Rudge P, Smith H. Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet. 1984; 2(8396): 181-184. PubMed | Google Scholar

  11. Lee CW, Chang WH, Shih SC, Wang TE, Chang CW, Bair MJ. Gastrointestinal tract pseudo-obstruction or obstruction due to Mycobacterium tuberculosis breakthrough. International Journal of Infectious Diseases. 2009; 13(4): e185-187. PubMed | Google Scholar

  12. Ha HK, Ko GY, Yu ES, Yoon K, Hong WS, Kim HR et al. Intestinal tuberculosis with abdominal complications: radiologic and pathologic features. Abdom Imaging. 1999; 24(1): 32-38. PubMed | Google Scholar

  13. Kulkarni S, Vyas S, Supe A, Kadival G. Use of polymerase chain reaction in the diagnosis of abdominal tuberculosis. J Gastroenterol Hepatol. 2006; 21(5): 819-23. PubMed | Google Scholar

  14. Tandon HD, Prakash A. Pathology of intestinal tuberculosis and its distinction from Crohn's disease. Gut. 1972; 13(4): 260-269. PubMed | Google Scholar

  15. Shah KK, Pritt BS, Alexander MP. Histopathologic review of granulomatous inflammation. Journal of clinical tuberculosis and other Mycobacterial Diseases. 2017; 7: 1-12. Google Scholar

  16. Shah I, Chilkar S, Patil M, Uma A. Acute respiratory distress during paradoxical reaction to antituberculous therapy in an 8-month-old child. Lung India. 2012; 29(4): 382-383. PubMed | Google Scholar

  17. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016; 63(7): e147-e195. PubMed | Google Scholar

  18. Jullien S, Jain S, Ryan H, Ahuja V. Six-month therapy for abdominal tuberculosis. Cochrane Database of Systematic Reviews. 2016; 11: CD012163. PubMed | Google Scholar